News Releases

Year

01 Apr '24

Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results

SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Apr. 1, 2024-- Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology designed to leverage a patient’s own biology to deliver rare disease therapeutics, today provided an update on

PDF Version

22 Feb '24

Quince Therapeutics Launches Scientific Advisory Board

World-renowned scientists and clinicians to provide expert insight and advice to support advancement of the company’s lead Phase 3 asset, new indications, and pipeline expansion SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Feb. 22, 2024-- Quince Therapeutics, Inc.

PDF Version

15 Feb '24

Quince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of Directors

SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Feb. 15, 2024-- Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology that leverages a patient’s own biology to deliver rare disease therapeutics, today announced the appointment

PDF Version

07 Feb '24

Quince Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference

SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Feb. 7, 2024-- Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology that leverages a patient’s own biology to deliver rare disease therapeutics, today announced that Dirk Thye ,

PDF Version

04 Jan '24

Quince Therapeutics to Participate at Investor Events in January 2024

SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jan. 4, 2024-- Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology that leverages a patient’s own biology to deliver rare disease therapeutics, today announced that Dirk Thye ,

PDF Version